Health Privacy From Global Bureaucrats Act

Bill Number

H.R. 5006

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-08-19: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Last Updated

2025-09-19T14:23:24Z

AI-Generated Summary

Purpose

The "Health Privacy From Global Bureaucrats Act" (H.R. 5006) aims to safeguard sensitive U.S. data by preventing its sharing with international entities. Specifically, it seeks to block the release of taxpayer, patient, and vaccine information to the World Health Organization (WHO) or any foreign government, emphasizing national control over personal and health-related data.

Key Provisions

• Prohibition on Data Release: The Secretary of Health and Human Services (HHS) and the Secretary of the Treasury must take all necessary steps to prevent the sharing of specified data with the WHO or foreign governments.
• Covered Data: This includes taxpayer information (e.g., financial details from tax records), patient data (e.g., medical records and health information), and vaccine data (e.g., records of vaccinations and related health metrics) that are under the control of HHS or the Treasury Department.
• Scope: The prohibition applies only to data managed by these two federal departments, focusing on international organizations and foreign entities.

Significant Changes to Existing Law

• This bill introduces an explicit federal ban on sharing certain types of sensitive data with the WHO or foreign governments, which may not have been directly prohibited before. Previously, data sharing could occur under international agreements, health treaties, or routine collaborations (e.g., for global health monitoring), but this act mandates proactive blocking actions by HHS and Treasury, potentially overriding or limiting such practices without congressional approval.

Potential Impacts

• On Government Agencies: HHS and the Treasury Department will need to implement new policies, audits, or technical safeguards to ensure compliance, which could increase administrative burdens and costs for data management.
• On Citizens: U.S. taxpayers and patients may gain stronger privacy protections for their personal health and financial information, reducing risks of unauthorized international access, though it might limit global health data contributions that could benefit public health responses.
• On International Relations: The U.S. could face tensions with the WHO and partner nations, as this may hinder collaborative efforts on global health issues like pandemics or vaccine tracking, potentially affecting diplomatic ties or U.S. participation in international health initiatives.

Main Stakeholders Affected

• U.S. Citizens and Patients: Primary beneficiaries through enhanced data privacy, particularly those with tax filings, medical histories, or vaccination records.
• Federal Agencies: HHS (oversees health data like patient and vaccine records) and the Treasury Department (manages taxpayer information) are directly responsible for enforcement.
• International Organizations and Governments: The WHO and foreign governments may lose access to U.S. data, impacting their research, policy-making, or health surveillance activities.
• Healthcare Providers and Researchers: Entities relying on federal data for studies or programs could see indirect effects if international collaborations are curtailed.

Notable Legal, Constitutional, or Political Implications

• Legal Implications: The bill strengthens data privacy under U.S. law by creating a clear prohibition, potentially aligning with existing privacy statutes like HIPAA (Health Insurance Portability and Accountability Act, which protects patient health information). However, it could conflict with international treaties or executive agreements on health data sharing, requiring legal clarification.
• Constitutional Implications: It reinforces congressional authority over executive branch actions (e.g., directing secretaries to act), but might raise questions about separation of powers if it limits the president's foreign affairs discretion. No direct challenges to free speech or due process are evident.
• Political Implications: The legislation reflects concerns over national sovereignty and data security in global health governance, potentially fueling debates on U.S. engagement with multilateral organizations like the WHO. It was introduced in the 119th Congress and referred to committees on Energy and Commerce and Ways and Means, indicating bipartisan or partisan scrutiny on privacy versus international cooperation.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Steube, W. Gregory [R-FL-17]

Recent Actions

• 2025-08-19: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-08-19: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-08-19: Introduced in House
• 2025-08-19: Introduced in House

Bill Versions

• Health Privacy From Global Bureaucrats Act — issued 2025-08-19 — PDF (2 pages)